How do you counsel patients with RA stable on csDMARDs on whether to attempt tapering or not?

It is important to recognize that this counseling is highly individualized and that factors such as risks of medication toxicity, age, comorbidities and disease severity all play a part. However, several studies have demonstrated a significantly increased risk of RA flares and radiographic progressi...

This is an important discussion with patients as an estimated 15% of patients in remission self-discontinue therapy with unpredictable morbidity and optimally trialed with supervision/shared decision-making. In RA patients within 3 years of their initial diagnosis, I raise this issue after they have...